Rxcurve
HCPCS J8530 · per 25 MG

Cyclophosphamide oral 25 mg

Products billed under this code include Cyclophosphamide.

Payment limit per 25 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J8530

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Cyclophosphamide Hikma Pharmaceuticals USA Inc. 00054-0382-25 100 $123.30
Cyclophosphamide Hikma Pharmaceuticals USA Inc. 00054-0383-25 200 $246.60
Cyclophosphamide Baxter Healthcare Corporation 10019-0984-01 200 $246.60
Cyclophosphamide Cipla USA, Inc. 69097-0516-07 100 $123.30
Cyclophosphamide Cipla USA, Inc. 69097-0517-07 200 $246.60

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $1.233 −$0.258 25 MG Cyclophosphamide oral 25 mg v1, posted September 17, 2026
3Q26 $1.491 −$0.158 25 MG Cyclophosphamide oral 25 mg v1, posted September 15, 2026
2Q26 $1.649 −$0.17 25 MG Cyclophosphamide oral 25 mg v1, posted September 15, 2026
1Q26 $1.819 +$0.722 25 MG Cyclophosphamide oral 25 mg v1, posted September 15, 2026
4Q25 $1.097 −$0.885 25 MG Cyclophosphamide oral 25 mg v1, posted September 8, 2026
3Q25 $1.982 +$0.843 25 MG Cyclophosphamide oral 25 mg v1, posted March 10, 2026
2Q25 $1.139 +$0.303 25 MG Cyclophosphamide oral 25 mg v1, posted March 10, 2026
1Q25 $0.836 −$0.047 25 MG Cyclophosphamide oral 25 mg v1, posted December 19, 2025
4Q24 $0.883 −$0.079 25 MG Cyclophosphamide oral 25 mg v1, posted June 11, 2025
3Q24 $0.962 +$0.103 25 MG Cyclophosphamide oral 25 mg v1, posted June 11, 2025
2Q24 $0.859 +$0.241 25 MG Cyclophosphamide oral 25 mg v1, posted March 11, 2025
1Q24 $0.618 −$0.388 25 MG Cyclophosphamide oral 25 mg v1, posted December 19, 2024
4Q23 $1.006 +$0.053 25 MG Cyclophosphamide oral 25 mg v1, posted October 10, 2024
3Q23 $0.953 +$0.058 25 MG Cyclophosphamide oral 25 mg v1, posted June 5, 2024
2Q23 $0.895 +$0.222 25 MG Cyclophosphamide oral 25 mg v1, posted February 23, 2024
1Q23 $0.673 +$0.091 25 MG Cyclophosphamide oral 25 mg v1, posted December 6, 2023
4Q22 $0.582 −$0.173 25 MG Cyclophosphamide oral 25 mg v1, posted June 22, 2023
3Q22 $0.755 −$0.223 25 MG Cyclophosphamide oral 25 mg v1, posted June 9, 2023
2Q22 $0.978 +$0.094 25 MG Cyclophosphamide oral 25 mg v1, posted December 14, 2022
1Q22 $0.884 +$0.078 25 MG Cyclophosphamide oral 25 mg v1, posted June 8, 2022
4Q21 $0.806 −$0.337 25 MG Cyclophosphamide oral 25 mg v1, posted June 2, 2022
3Q21 $1.143 −$0.324 25 MG Cyclophosphamide oral 25 mg v1, posted June 2, 2022
2Q21 $1.467 −$0.156 25 MG Cyclophosphamide oral 25 mg v1, posted March 1, 2022
1Q21 $1.623 – 25 MG Cyclophosphamide oral 25 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files